The present invention concerns a method of improving global response to allergen desensitization, by allergen immunotherapy, which comprises classifying allergic patients as eligible to allergen immunotherapy based on the patients' allergen-specific T cell reactivity against the allergen
METHOD FOR CLASSIFYING AN ALLERGIC PATIENT AS ELIGIBLE TO ALLERGEN IMMUNOTHERAPY